Contera Pharma is a Danish biotech company with an affiliate in Seoul, South-Korea. We develop innovative therapies to improve life for people suffering from neurological disorders.
Thomas Sager is Ph.D. in neuroscience and has more 24 years’ experience in drug discovery. After receiving his Ph.D. degree, he has been working in both the biotech and pharma industry. The focus of his professional career has always been ascribed to disorders within the central nervous system and related disorders with the ambition to seek new treatments options.